Researchers at BU begin Experimenting with Ebola

A lab in Boston was approved to study one of the world’s deadliest viruses.

On Thursday, Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) announced in a press release that they have started experimenting with the Ebola virus.

NEIDL microbiologist Elke Mühlberger said the lab’s first project will examine how the Ebola virus damages cells in the liver and why it triggers such a powerful inflammatory response.

Mühlberger said the answers to those questions could speed the development of how to treat the Ebola virus disease. In a 2014-2016 outbreak, the virus led to more than 11,000 deaths in West Africa. And a few months ago in May, an Ebola outbreak in the Democratic Republic of Congo killed 29 people.

The researchers at NEIDL are also experimenting with the Marbug virus. Like Ebola, Marburg is deadly and causes convulsions and bleeding of mucous membranes, skin and organs, according to the Centers for Disease Control and Prevention.

Mühlberger said their plans include at least three projects involving both the Ebola and Marburg viruses. But the first step of their work will be growing the rare Level-4 pathogens to produce enough materials for their experiments.

Click to read full article & watch video on Boston 25 News